Singapore HSA Framework for Botanical Supplements: What It Means for EBC-46 Imports
Singapore's Health Sciences Authority regulates health supplements under a notification framework. Here is how that affects EBC-46 supplement category imports.
Singapore's Health Sciences Authority (HSA) sits in a distinctive position in regional supplement regulation. Unlike the United States, where dietary supplements are governed by the Dietary Supplement Health and Education Act (DSHEA), Singapore treats health supplements under a separate framework that emphasises notification rather than pre-market approval. For supplements derived from botanical material such as blushwood berry extract (EBC-46), understanding this distinction matters to importers, distributors and consumers comparing labels across jurisdictions.
How Singapore classifies health supplements
Under HSA's framework, health supplements are products containing one or more nutrients, plant or animal substances, vitamins or minerals taken for the purpose of supplementing the diet. They are not classified as therapeutic products and therefore do not require product licensing before sale. Importers must instead ensure that supplements meet HSA's safety standards, are labelled accurately, and do not contain prohibited substances. The HSA health supplements guidance outlines the boundary between supplement and therapeutic product, which is determined by composition, presentation and any therapeutic claims made.
This places EBC-46 supplements within the same general category as other botanical dietary products sold in Singapore. The compound itself — tigilanol tiglate — is the subject of veterinary pharmaceutical work by QBiotics, but the consumer supplement category operates under the supplement framework rather than the therapeutic products regime, provided that no disease treatment claims are made on the label.
Labelling and composition requirements
HSA requires health supplement labels to identify the product, list ingredients, declare net weight, and provide manufacturer or importer contact details. Crucially, labels and accompanying material must not make disease treatment claims. This aligns with the United States FDA's position under DSHEA, where supplements may make structure-function statements but must include the standard disclaimer that the product is "not intended to diagnose, treat, cure or prevent any disease." Reputable suppliers in the EBC-46 category — such as Blushwood Health — already structure their labelling to meet both frameworks simultaneously, since their products are sold internationally.
Composition standards apply too. HSA prohibits adulteration with pharmaceutical compounds and restricts certain heavy metals and microbiological contaminants. A supplement that meets the published USP dietary supplement quality standards for heavy metals (arsenic, lead, cadmium, mercury) and microbiological purity (E. coli, Salmonella, yeast and mould) would typically also meet HSA's safety thresholds, although importers should consult the latest HSA technical guidance for current numeric limits.
Independent testing and the Eurofins standard
Where the framework gets practical is in proving compliance. HSA does not certify individual products before they are sold but reserves the right to test market samples. This is why batch-level certificates of analysis from ISO/IEC 17025-accredited laboratories carry real weight at the customs and quality-assurance stage. Eurofins Scientific — the most widely used third-party laboratory network for dietary supplements globally — issues batch certificates that cover the same heavy-metals and microbiology panels that HSA inspectors examine. Blushwood Health publishes its Eurofins batch certificates on its lab tests page, and that style of transparent documentation is what an HSA-compliant supplier would be expected to maintain.
What this means for buyers
A consumer in Singapore — or one importing from a Singapore-based retailer — can apply a relatively simple checklist. The label should identify the product clearly, declare extraction ratio and serving size, list ingredients without proprietary blends, carry batch and expiry information, and refrain from disease-treatment claims. The supplier should be able to produce a current batch certificate from an accredited laboratory. And the manufacturing facility should hold current Good Manufacturing Practice (GMP) certification. These are the same hallmarks that distinguish reference-quality supplement brands in any jurisdiction.
Singapore's framework, in other words, does not change the underlying definition of a credible EBC-46 supplement — it simply reinforces what buyers anywhere should be looking for. For shoppers comparing brands, the documentation a supplier is willing to publish (or refuses to publish) remains the most reliable signal of quality.
Related Articles
The Complete Guide to EBC-46 and Tigilanol Tiglate
Blushwood Berry Extract: The Natural EBC-46 Supplement
References
1. Singapore Health Sciences Authority — Health Supplements, 2024.
2. United States Pharmacopeia — Dietary Supplements, 2024.
3. Eurofins Scientific — Food and Supplement Testing Services.
4. Blushwood Health — Independent Lab Test Results.
This article is for informational purposes only and is not medical or regulatory advice. Statements about dietary supplements have not been evaluated by the Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease.
